1. Search Result
Search Result
Results for "


" in MCE Product Catalog:
Cat. No. Product Name Target Research Areas
  • HY-145702

    MEK ERK Cancer
    MAP855 is a highly potent, selective, ATP-competitive and orally active MEK1/2 kinase inhibitor (MEK1 ERK2 cascade IC50=3 nM, pERK EC50=5 nM). MAP855 shows equipotent inhibition of wild-type and mutant MEK1/2.